Phosphoinositide 3-kinase in Health and Disease

Edited by Christian Rommel - Bart Vanhaesebroeck - Peter K. Vogt

Phosphoinositide 3-kinase in Health and Disease

Edited by Christian Rommel, Bart Vanhaesebroeck, Peter K. Vogt

Publisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. K

Series: Current Topics in Microbiology and Immunology

Deastore.com price (info) $ 226.48

Shipping Costs: 0€ FREE Shipping by Standard Mail Details

Format: Hardback

Publication date: 01 October 2010

Usually shipped within: (info) 7 working days

ISBN: 3642148158 ISBN 13: 9783642148156

Phosphoinositide 3-kinase in Health and Disease

PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis. This book details key discoveries in the area, their impact and future directions. Top page

Complete description

PI3K has become a very intense area of research, with over 2000 publications on PI3K in PubMed for 2009 alone. The expectations for a therapeutic impact of intervention with PI3K activity are high, and progress in the clinical arena is being monitored by many. However, targeted therapies almost invariably encounter roadblocks, often exposing unresolved questions in the basic understanding of the target. Top page

General info

Publisher & Imprint: Springer-Verlag Berlin and Heidelberg GmbH & Co. K

City: Berlin

Pages: 316

More info: height 235 mm width 155 mm weight 695 gr thickness 23 mm

Top page

Age recommended: College/higher education

Subject Indexing & Classification Dewey:(DC22) 572.757

Departments: Oncology;

Record updated at: 05 April, 2013 time: 21:13

Summary Phosphoinositide 3-kinase in Health and Disease PI3K - From the bench to the clinic and back.- Oncogenetic mutations of PIK3CA in human cancers.- Structural effects of oncogenic PI3Kalpha mutations.- Comparing the roles of the p110i ! and p110i isoforms of PI3K in signaling and cancer.- Phophatidylinositol 3-kinase (PI3K): the oncoprotein.- AKT Signaling in Physiology and Disease.- Faithfull modeling of PTEN loss driven diseases in the mouse.- PI3K as a target for therapy in haematological malignancies.- Clinical Development of Phosphatidylinositol-3 Kinase Pathway Inhibitors.- From the bench to the bed side: PI3K pathway inhibitors in clinical development.- New Inhibitors of the PI3K-Akt-mTOR Pathway: Insights into mTOR Signaling From a New Generation of Tor Kinase Domain Inhibitors (TORKinibs).- Small molecule inhibitors of the PI3-kinase family.- Targeting the RTK-PI3K-mTOR axis in malignant glioma: overcoming resistance.- Subject index Contents of sister volume 1: PI3K Book Introduction.- PDK1: The major transducer of PI 3-kinase actions.- Protein Kinase B (PKB/Akt), a key mediator of the PI3K signaling pathway.- Regulatory subunity of class IA PI3K.- The Regulation of Class IA PI 3-kinases by Inter-Subunit Interactions.- Phosphoinositide signalling pathways in metabolic regulation.- Role of RAS in the regulation of PI 3-kinase.- More than just kinases: the scaffolding function of PI3K.- PI3K signalling in neutrophils.- PI 3-kinase p110i Regulation of Platelet Integrin i !IIbi 3.- PI3Ks in lymphocyte signaling and development.- the neurodevelopmental implication of PI3K signaling.- PI3kinase regulation of skeletal muscle hypertrophy and atrophy.- Taking PI3Kdelta and PI3Kgamma one step ahead - Dual active PI3Kdelta/gamma inhibotrs for the treatment of immune -mediated inflammatory diseases.- Subject index Top page

Add your comment

Add a review - Highlight this book to a friend

Please login or register to send your review

Top page
More books from the same department

Buying in deastore.com
is safe!